Purification, characterization and selective inhibition of human prostaglandin G/H synthase 1 and 2 expressed in the baculovirus system
about
Interaction of cyclooxygenases with an apoptosis- and autoimmunity-associated proteinAgglomerates of ultrafine particles of elemental carbon and TiO2 induce generation of lipid mediators in alveolar macrophagesKaposi's sarcoma associated herpesvirus G-protein coupled receptor activation of cyclooxygenase-2 in vascular endothelial cellsEffects of NSAIDs on the Inner Ear: Possible Involvement in Cochlear Protection.Novel Activities of Select NSAID R-Enantiomers against Rac1 and Cdc42 GTPasesVoltage-Dependent Inhibition of Glycine Receptor Channels by Niflumic AcidThe effect of celecoxib, a cyclooxygenase-2 inhibitor on noise- induced hearing loss.High-throughput quantification of bioactive lipids by MALDI mass spectrometry: application to prostaglandinsA high-throughput chemically induced inflammation assay in zebrafish.Effect of NS-398 on colon cancer cellsCyclooxygenase-1 null mice show reduced neuroinflammation in response to beta-amyloid.Analysis of Gene Expression in Human Dermal Fibroblasts Treated with Senescence-Modulating COX Inhibitors.Characterization of the heme environment in Arabidopsis thaliana fatty acid alpha-dioxygenase-1Blockade of leukocyte haptokinesis and haptotaxis by ketoprofen, diclofenac and SC-560.Mechanism of radiation-induced bystander effect: role of the cyclooxygenase-2 signaling pathwayThe prostaglandin transporter PGT transports PGH(2).Beneficial effect of ultra-low-dose aspirin in platelet activity alterations and haemorrhage observed in experimental portal hypertension.Lipopolysaccharide-induced expression of microsomal prostaglandin E synthase-1 mediates late-phase PGE2 production in bone marrow derived macrophages.Biosynthesis of hemiketal eicosanoids by cross-over of the 5-lipoxygenase and cyclooxygenase-2 pathways.Development of an ultra fast online-solid phase extraction (SPE) liquid chromatography electrospray tandem mass spectrometry (LC-ESI-MS/MS) based approach for the determination of drugs in pharmacokinetic studies.Infection of human endothelial cells with spotted Fever group rickettsiae stimulates cyclooxygenase 2 expression and release of vasoactive prostaglandinsCyclooxygenase-2 deficiency leads to intestinal barrier dysfunction and increased mortality during polymicrobial sepsis.Development of potent and selective inhibitors of aldo-keto reductase 1C3 (type 5 17β-hydroxysteroid dehydrogenase) based on N-phenyl-aminobenzoates and their structure-activity relationships.Human cyclooxygenase-1 activity and its responses to COX inhibitors are allosterically regulated by nonsubstrate fatty acids.Decreased cyclooxygenase inhibition by aspirin in polymorphic variants of human prostaglandin H synthase-1.Identification and functional characterization of polymorphisms in human cyclooxygenase-1 (PTGS1).Cyclooxygenase-2 inhibitors modulate skin aging in a catalytic activity-independent mannerStructure-activity relationship of fenamates as Slo2.1 channel activators.Immunogenetic programs for viral induction of mucous cell metaplasiaInterleukin-1beta induces glycosaminoglycan synthesis via the prostaglandin E2 pathway in cultured human cervical fibroblasts.Genetic deletion or pharmacological inhibition of cyclooxygenase-1 attenuate lipopolysaccharide-induced inflammatory response and brain injury.Inhibition of cyclooxygenase activity blocks cell-to-cell spread of human cytomegalovirusGenotoxic responses to titanium dioxide nanoparticles and fullerene in gpt delta transgenic MEF cells.Peroxide-induced radical formation at TYR385 and TYR504 in human PGHS-1Prostaglandin H synthase: resolved and unresolved mechanistic issues.Self-delivery multifunctional anti-HIV hydrogels for sustained release.Kinetic basis for selective inhibition of cyclo-oxygenasesD-amino acids boost the selectivity and confer supramolecular hydrogels of a nonsteroidal anti-inflammatory drug (NSAID).In the presence of L-NAME SERCA blockade induces endothelium-dependent contraction of mouse aorta through activation of smooth muscle prostaglandin H2/thromboxane A2 receptors.Augmented cyclooxygenase-2 effects on renal function during varying states of angiotensin II.
P2860
Q24604296-DBAD8DE5-324A-466F-ABBA-E38D450617CCQ24814554-192D5705-54FF-4A5D-8EE5-DBCECFB675EDQ28221605-85528FFD-655E-434E-B50D-A5291826A18AQ28386639-CC5D65D0-2A88-425B-8B8F-A88A616EC66AQ28550876-1F0BD229-55CB-4590-8779-B08B68FD1455Q30355589-9703895D-74F9-4161-9449-64A84D474CC5Q30452689-82CCBB61-5A2D-4C68-9648-5F510EEEECBFQ30464000-F21B5AB6-0A1A-436A-97D9-9A8ACB8DD8ECQ30497926-771E0369-C85D-4CE8-BD61-364F74853447Q31139481-E9FB9459-CB06-4773-A32D-E6520D4A4315Q33588687-DAE8344C-A68B-4AAE-BE40-327E5850BBA7Q33819277-53D5E2F6-8B21-4B35-AD90-92AA0CF7B7D6Q33820133-03D4AF1D-C383-4DF6-ACAC-253F66A16493Q34073053-8B13C0D4-9296-4E07-A2E8-E15424D8AF53Q34078442-BDBA664F-5A69-426F-9B3C-A47CCEE81132Q34106984-A39B95D3-DF80-4E7A-AB69-6251DB0DDD38Q34111114-1B924837-A0D2-4FCF-B655-F95C5E263B71Q34505205-73F515B0-F8A1-43BD-96CB-1D58FBF51EADQ34880320-E06DD8F8-39C8-4374-A310-EB78FF7C197CQ35030893-123CC35B-77D2-4468-8E2E-13156F66D495Q35073759-BF93B157-D5AE-4DA4-849D-55AFAB5E0E72Q35523910-7756551C-C1E9-4CFF-B59D-65932310CF0CQ35816836-20D7133A-8DD4-4562-8B1A-B6DC44972EC8Q36020274-F9CF79DA-1FD1-44CD-A045-B04DB053CE60Q36035412-FFE39C4B-8CFD-4889-84D7-B79C2D3106CEQ36091906-9F7E3116-F45B-43B6-8879-490ABDC2BE9BQ36301859-DE8BD71B-0194-4950-98C0-93557D6AD5B9Q36335587-5DFFEA1A-022C-4300-A9BC-3CA6CE11E64CQ36423688-04302342-5F3E-4593-A5A1-77E68BD3BAA5Q36456591-ECE7D8EB-F297-4FDE-9AE0-11928D3D7BA5Q36662869-7DBA2A17-785C-4B73-80AE-DA50BD249E5FQ37039604-11CF6F0D-C7A8-4A93-92A1-B42D7D3F4716Q37116054-0D5971AC-DF93-49A9-8367-C6D9A13B26F7Q37229279-FE8619FE-9FE0-4B0F-9A34-4287D37705C3Q37591564-8570A54A-2012-4984-A690-E9C45B6C7699Q37601822-243AF002-B8E3-40E9-857F-DAE4F6710F5BQ41817795-0F19CD69-3E34-41DC-9674-AC932A7DC785Q41885961-816FFF50-2974-42D1-A6CC-7EAE724E027DQ41998575-04C7ADB7-7A47-43D0-B7AB-2233A38D20D5Q42365329-54F2BF24-09C0-48A7-BB08-46E3DAC50497
P2860
Purification, characterization and selective inhibition of human prostaglandin G/H synthase 1 and 2 expressed in the baculovirus system
description
1994 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 1994
@ast
im November 1994 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1994/11/16)
@sk
vědecký článek publikovaný v roce 1994
@cs
wetenschappelijk artikel (gepubliceerd op 1994/11/16)
@nl
наукова стаття, опублікована в листопаді 1994
@uk
مقالة علمية (نشرت في 16-11-1994)
@ar
name
Purification, characterization ...... ssed in the baculovirus system
@ast
Purification, characterization ...... ssed in the baculovirus system
@en
Purification, characterization ...... ssed in the baculovirus system
@nl
type
label
Purification, characterization ...... ssed in the baculovirus system
@ast
Purification, characterization ...... ssed in the baculovirus system
@en
Purification, characterization ...... ssed in the baculovirus system
@nl
prefLabel
Purification, characterization ...... ssed in the baculovirus system
@ast
Purification, characterization ...... ssed in the baculovirus system
@en
Purification, characterization ...... ssed in the baculovirus system
@nl
P2093
P1476
Purification, characterization ...... ssed in the baculovirus system
@en
P2093
R Mackenzie
P304
P356
10.1016/0167-4838(94)90148-1
P407
P577
1994-11-01T00:00:00Z